Delta-Aminolaevulinic acid and amino acid neurotransmitters
- PMID: 6117007
- DOI: 10.1007/BF00235687
Delta-Aminolaevulinic acid and amino acid neurotransmitters
Abstract
The effects of the porphyrin precursor delta-aminolaevulinic acid (ALA) on gamma-aminobutyric acid (GABA) and L-glutamate transmitter systems was investigated in rat brain. It was found that ALA inhibited GABA and glutamate uptake and stimulated basal efflux of the amino acids in purified nerve endings. These effects were evident only at relatively high concentrations of ALA (at least 100 microM). Such concentrations probably do not occur in the nervous systems of patients suffering from acute porphyria. In addition, it was found that ALA inhibited the stimulated release of GABA from nerve endings probably by acting as an agonist at GABA autoreceptors. This effect was found at very low concentrations of ALA (1 microM). It is therefore likely that the neuropsychiatric manifestations of the acute porphyric attack are attributable, to some extent, to reduced GABA release at central synapses.
Similar articles
-
The effect of delta-aminolaevulinic acid on the high affinity uptake of aspartic acid by rat brain synaptosomes.Gen Pharmacol. 1984;15(6):553-5. doi: 10.1016/0306-3623(84)90215-5. Gen Pharmacol. 1984. PMID: 6526266
-
The effects of delta-aminolaevulinic acid on the uptake and efflux of amino acid neurotransmitters in rat brain synaptosomes.J Neurochem. 1979 Sep;33(3):721-5. doi: 10.1111/j.1471-4159.1979.tb05217.x. J Neurochem. 1979. PMID: 479886 No abstract available.
-
Effect of delta-aminolaevulinic acid on GABA receptor binding in synaptic plasma membranes.Int J Biochem. 1980;12(5-6):833-5. doi: 10.1016/0020-711x(80)90172-x. Int J Biochem. 1980. PMID: 6256221 No abstract available.
-
Amino acid transport in isolated neurons and glia.Adv Exp Med Biol. 1976;69:221-36. doi: 10.1007/978-1-4684-3264-0_17. Adv Exp Med Biol. 1976. PMID: 7926 Review.
-
The uptake and release of putative amino acid neurotransmitters.Neuroscience. 1979;4(8):1015-36. doi: 10.1016/0306-4522(79)90185-4. Neuroscience. 1979. PMID: 40156 Review. No abstract available.
Cited by
-
Pathogenesis of acute encephalopathy in acute hepatic porphyria.J Neurol. 2023 May;270(5):2613-2630. doi: 10.1007/s00415-023-11586-5. Epub 2023 Feb 9. J Neurol. 2023. PMID: 36757574 Free PMC article.
-
Proceedings of the British Pharmacological Society. University of Manchester, 13-15 September 1989.Br J Pharmacol. 1989 Dec;98 Suppl(Suppl):775P-952P. Br J Pharmacol. 1989. PMID: 2611500 Free PMC article. No abstract available.
-
Cutting-Edge Therapies and Novel Strategies for Acute Intermittent Porphyria: Step-by-Step towards the Solution.Biomedicines. 2022 Mar 11;10(3):648. doi: 10.3390/biomedicines10030648. Biomedicines. 2022. PMID: 35327450 Free PMC article. Review.
-
An update of clinical management of acute intermittent porphyria.Appl Clin Genet. 2015 Sep 1;8:201-14. doi: 10.2147/TACG.S48605. eCollection 2015. Appl Clin Genet. 2015. PMID: 26366103 Free PMC article. Review.
-
Are delta-aminolevulinate dehydratase inhibition and metal concentrations additional factors for the age-related cognitive decline?Int J Environ Res Public Health. 2014 Oct 17;11(10):10851-67. doi: 10.3390/ijerph111010851. Int J Environ Res Public Health. 2014. PMID: 25329536 Free PMC article.